IGEM Therapeutics Completes Initial Closing of Series A Financing; Appoints CEO
June 20, 2017
Raises £2 million from Epidarex Capital to progress pipeline of IgE antibody drug candidates to treat cancer IgE antibodies shown to offer greater efficacy than